Related Experiment Videos

Improving insight into radiobiology and radionuclide therapy

Stanley J Goldsmith¹

¹New York Weill Cornell Medical Center, New York, New York, USA.

Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine

|July 6, 2004

Summary

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Targeted Radionuclide Therapy: A Historical and Personal Review.

Seminars in nuclear medicine·2019

Phase 1/2 study of fractionated dose lutetium-177-labeled anti-prostate-specific membrane antigen monoclonal antibody J591 (177 Lu-J591) for metastatic castration-resistant prostate cancer.

Cancer·2019

Phase 1 Study of High-Specific-Activity I-131 MIBG for Metastatic and/or Recurrent Pheochromocytoma or Paraganglioma.

The Journal of clinical endocrinology and metabolism·2017

Radioactive Iodine Therapy of Differentiated Thyroid Carcinoma: Redesigning the Paradigm.

Molecular imaging and radionuclide therapy·2017

(90)Y-clivatuzumab tetraxetan with or without low-dose gemcitabine: A phase Ib study in patients with metastatic pancreatic cancer after two or more prior therapies.

European journal of cancer (Oxford, England : 1990)·2015

Use of radiopharmaceuticals in diagnostic nuclear medicine in the United States: 1960-2010.

Health physics·2015

See all related articles